In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time.

After losing significant ground to rival Eli Lilly in the GLP-1 space over the past two years, Novo Nordisk is defending the ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be ...

She called it a 'violation'.

For decades, researchers have been looking for an effective weight-loss pill. But the recent success of glucagon-like peptide-1 (GLP-1) weight-loss injections has sparked new hope — especially for ...

It’s no secret that Ozempic is a miracle drug that has changed how patients approach weight loss and other common concerns, such as glucose levels. The once hard-to-get prescription drug is now ...

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.

Orforglipron, Eli Lilly’s oral obesity drug, is under FDA review with a decision expected in April. The pharma has also filed for marketing authorization for the pill in China.

If you have obesity and are curious whether a weight loss medication could help you improve your health, there are a number of weight loss pills on the market to consider, both old and new.

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...